Voima Ventures
Edit

Voima Ventures

https://www.voimaventures.com
Last activity: 22.10.2024
Active
Voima Ventures helps founders to accelerate the growth of deep technology ventures to global markets. We shed light on the ideas and technology which require time and courage to build.

The way we work is simple: we combine science-driven innovation together with the Nordic serial entrepreneurial experience and a global mindset.
Likes
733
Portfolio
4
Mentions
44
Location: Finland, Mainland Finland, Helsinki
Employees: 1-10
Investment Type: Venture Capital
Investment Stage: Seed

Portfolio 4

DateNameWebsiteTotal RaisedLocation
12.01.2024n-inkn-ink.com$1.1MSweden
21.06.2023Alba Healt...albahealth.co$2.5MSweden, St...
07.11.2022Nucunucubaby.com$948.25KFinland, N...
09.12.2019Geyser Bat...geyserbatteries.com$1.11MFinland, M...

Mentions in press and media 44

DateTitleDescription
22.10.2024Helsinki-based Avenue Biosciences raises €2.3 million to scale AI-enhanced protein engineeringAvenue Biosciences, a transatlantic biotechnology company specialising in novel protein engineering technologies, announced the successful closing of their €2.3 million seed financing round. Led by Voima Ventures, with additional participat...
30.08.2024Betolar Plc: Managers' Transactions – Voima Ventures Fund II KyBetolar Plc: Managers' Transactions – Voima Ventures Fund II Ky Fri, Aug 30, 2024 18:00 CET Report this content Betolar Plc Company Announcement 30 August 2024 at 7:00 p.m. EEST Betolar Plc: Managers' Transactions – Voima Ventures Fund II K...
22.08.2024The Rise of Alternative Proteins: A New Era in Sustainable Food ProductionThe world is changing. The way we produce food is evolving. As climate change looms and populations swell, the demand for sustainable food sources grows louder. Enter the realm of alternative proteins. This sector is not just a trend; it’s ...
22.08.2024NADMED raises €3.5M to bring NAD tests to international markets, advancing personalized treatment optionsNADMED raises €3.5M to bring NAD tests to international markets, advancing personalized treatment options Thu, Aug 22, 2024 10:30 CET Report this content Finnish biotech company NADMED has developed the first test to measure all four bodily...
22.08.2024Biotech NADMED raises €3.5M series A for 'NAD' vitals testingFinnish biotech company NADMED has raised €3.5M for its blood testing technology. The round was led by Finnish science-based startup investor Nordic Science Investments (NSI). Additional funding was secured from previous investors Voima Ven...
22.08.2024Finnish biotech NADMED raises €3.5 million Series A for vitamin B3 deficiencies testingHelnsinki-based NADMED has closed a €3.5 million series A round to fund its entry to the U.S. and other international markets with its proprietary nicotinamide adenine dinucleotide (NAD) measurement technology that may help clinicians estab...
21.08.2024Solar Foods to List on Nasdaq, Bolstering Growth Plans for ‘Solein’ Air-Based ProteinAir-based protein developer Solar Foods announces plans to list on the Nasdaq First North Growth Market Finland. The listing is expected to occur in September as a technical listing without any share issue or sale. Based in Helsinki, the bi...
23.05.2024Enifer's Groundbreaking Journey: A New Era in Mycoprotein ProductionEnifer, a pioneering Finnish biotech startup, has recently made waves in the protein industry by securing an impressive €36 million in funding. This substantial investment is set to fuel the construction of a state-of-the-art mycoprotein fa...
23.05.2024Finland-based Enifer raises €36M to address global protein demand with its PEKILO mycoproteinRead this article in: Espoo-based Enifer, a biotech startup, has secured €36M in fresh funding to build a food-grade mycoprotein factory in Kirkkonummi, Finland. Set to be completed by the end of 2025 at a cost of €33M, the facility will co...
23.05.2024Biomass fermentation space heats up as Enifer raises $39m to scale mycoprotein plant in FinlandFinnish startup Enifer has raised €36 million ($39.1 million) from a mix of debt and equity to fund a large-scale facility growing a source of mycoprotein that was first commercialized as animal feed 50 years ago. The funding package includ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In